Chroma Medicine Announces Exclusive License Agreement with the Whitehead Institute for Novel Epigenetic Editing ...
License provides exclusive access to innovative epigenetic editors and expands the reach of Chroma's platform BOSTON, June 27, 2024 /PRNewswire/ -- Chroma Medicine, Inc. (Chroma) a genomic medicine company pioneering single-course epigenetic …